Renal Drugs Market 2028 By Drug Class, Route of Administration, Distribution Channel | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Renal Drugs Market - By Drug Class
1.3.2 Renal Drugs Market - By Route of Administration
1.3.3 Renal Drugs Market - By Distribution Channel
1.3.4 Renal Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RENAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RENAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RENAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. RENAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. RENAL DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RENAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ACE INHIBITORS
7.3.1. Overview
7.3.2. ACE Inhibitors Market Forecast and Analysis
7.4. ANGIOTENSIN-II RECEPTOR BLOCKERS
7.4.1. Overview
7.4.2. Angiotensin-II Receptor Blockers Market Forecast and Analysis
7.5. DIURETICS
7.5.1. Overview
7.5.2. Diuretics Market Forecast and Analysis
7.6. ANTIHYPERTENSIVE DRUGS
7.6.1. Overview
7.6.2. Antihypertensive Drugs Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. RENAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
9. RENAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. E-COMMERCE
9.5.1. Overview
9.5.2. e-commerce Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. RENAL DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Renal Drugs Market Overview
10.1.2 North America Renal Drugs Market Forecasts and Analysis
10.1.3 North America Renal Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America Renal Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Renal Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Renal Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Renal Drugs Market
10.1.6.1.1 United States Renal Drugs Market by Drug Class
10.1.6.1.2 United States Renal Drugs Market by Route of Administration
10.1.6.1.3 United States Renal Drugs Market by Distribution Channel
10.1.6.2 Canada Renal Drugs Market
10.1.6.2.1 Canada Renal Drugs Market by Drug Class
10.1.6.2.2 Canada Renal Drugs Market by Route of Administration
10.1.6.2.3 Canada Renal Drugs Market by Distribution Channel
10.1.6.3 Mexico Renal Drugs Market
10.1.6.3.1 Mexico Renal Drugs Market by Drug Class
10.1.6.3.2 Mexico Renal Drugs Market by Route of Administration
10.1.6.3.3 Mexico Renal Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Renal Drugs Market Overview
10.2.2 Europe Renal Drugs Market Forecasts and Analysis
10.2.3 Europe Renal Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Renal Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Renal Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Renal Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Renal Drugs Market
10.2.6.1.1 Germany Renal Drugs Market by Drug Class
10.2.6.1.2 Germany Renal Drugs Market by Route of Administration
10.2.6.1.3 Germany Renal Drugs Market by Distribution Channel
10.2.6.2 France Renal Drugs Market
10.2.6.2.1 France Renal Drugs Market by Drug Class
10.2.6.2.2 France Renal Drugs Market by Route of Administration
10.2.6.2.3 France Renal Drugs Market by Distribution Channel
10.2.6.3 Italy Renal Drugs Market
10.2.6.3.1 Italy Renal Drugs Market by Drug Class
10.2.6.3.2 Italy Renal Drugs Market by Route of Administration
10.2.6.3.3 Italy Renal Drugs Market by Distribution Channel
10.2.6.4 Spain Renal Drugs Market
10.2.6.4.1 Spain Renal Drugs Market by Drug Class
10.2.6.4.2 Spain Renal Drugs Market by Route of Administration
10.2.6.4.3 Spain Renal Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Renal Drugs Market
10.2.6.5.1 United Kingdom Renal Drugs Market by Drug Class
10.2.6.5.2 United Kingdom Renal Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Renal Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Renal Drugs Market Overview
10.3.2 Asia-Pacific Renal Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Renal Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Renal Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Renal Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Renal Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Renal Drugs Market
10.3.6.1.1 Australia Renal Drugs Market by Drug Class
10.3.6.1.2 Australia Renal Drugs Market by Route of Administration
10.3.6.1.3 Australia Renal Drugs Market by Distribution Channel
10.3.6.2 China Renal Drugs Market
10.3.6.2.1 China Renal Drugs Market by Drug Class
10.3.6.2.2 China Renal Drugs Market by Route of Administration
10.3.6.2.3 China Renal Drugs Market by Distribution Channel
10.3.6.3 India Renal Drugs Market
10.3.6.3.1 India Renal Drugs Market by Drug Class
10.3.6.3.2 India Renal Drugs Market by Route of Administration
10.3.6.3.3 India Renal Drugs Market by Distribution Channel
10.3.6.4 Japan Renal Drugs Market
10.3.6.4.1 Japan Renal Drugs Market by Drug Class
10.3.6.4.2 Japan Renal Drugs Market by Route of Administration
10.3.6.4.3 Japan Renal Drugs Market by Distribution Channel
10.3.6.5 South Korea Renal Drugs Market
10.3.6.5.1 South Korea Renal Drugs Market by Drug Class
10.3.6.5.2 South Korea Renal Drugs Market by Route of Administration
10.3.6.5.3 South Korea Renal Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Renal Drugs Market Overview
10.4.2 Middle East and Africa Renal Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Renal Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Renal Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Renal Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Renal Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Renal Drugs Market
10.4.6.1.1 South Africa Renal Drugs Market by Drug Class
10.4.6.1.2 South Africa Renal Drugs Market by Route of Administration
10.4.6.1.3 South Africa Renal Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Renal Drugs Market
10.4.6.2.1 Saudi Arabia Renal Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia Renal Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Renal Drugs Market by Distribution Channel
10.4.6.3 U.A.E Renal Drugs Market
10.4.6.3.1 U.A.E Renal Drugs Market by Drug Class
10.4.6.3.2 U.A.E Renal Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Renal Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Renal Drugs Market Overview
10.5.2 South and Central America Renal Drugs Market Forecasts and Analysis
10.5.3 South and Central America Renal Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Renal Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Renal Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Renal Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Renal Drugs Market
10.5.6.1.1 Brazil Renal Drugs Market by Drug Class
10.5.6.1.2 Brazil Renal Drugs Market by Route of Administration
10.5.6.1.3 Brazil Renal Drugs Market by Distribution Channel
10.5.6.2 Argentina Renal Drugs Market
10.5.6.2.1 Argentina Renal Drugs Market by Drug Class
10.5.6.2.2 Argentina Renal Drugs Market by Route of Administration
10.5.6.2.3 Argentina Renal Drugs Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RENAL DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RENAL DRUGS MARKET, KEY COMPANY PROFILES
13.1. APOTEX INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CARDINAL HEALTH, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. FRESENIUS SE AND CO. KGAA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DAVA PHARMACEUTICALS INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MYLAN N.V.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F. HOFFMANN-LA ROCHE AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ENDO INTERNATIONAL PLC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BAUSCH HEALTH COMPANIES INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SANOFI
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TEVA PHARMACEUTICALS INDUSTRIES LTD
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS